<bill session="115" type="s" number="3267" updated="2019-11-18T12:51:47Z">
  <state datetime="2018-07-25">REFERRED</state>
  <status>
    <introduced datetime="2018-07-25"/>
  </status>
  <introduced datetime="2018-07-25"/>
  <titles>
    <title type="official" as="introduced">A bill to establish a National Commission on Fibrotic Diseases.</title>
    <title type="short" as="introduced">National Commission on Scleroderma and Fibrotic Diseases Act of 2018</title>
    <title type="short" as="introduced">National Commission on Scleroderma and Fibrotic Diseases Act of 2018</title>
    <title type="display">National Commission on Scleroderma and Fibrotic Diseases Act of 2018</title>
  </titles>
  <sponsor bioguide_id="G000555"/>
  <cosponsors>
    <cosponsor bioguide_id="S000148" joined="2018-07-25"/>
  </cosponsors>
  <actions>
    <action datetime="2018-07-25">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-07-25" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="4638"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Congressional oversight"/>
    <term name="Government studies and investigations"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Musculoskeletal and skin diseases"/>
    <term name="Organ and tissue donation and transplantation"/>
    <term name="Research administration and funding"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2018-07-25T04:00:00Z" status="Introduced in Senate">National Commission on Scleroderma and Fibrotic Diseases Act of 2018

This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.</summary>
  <committee-reports/>
</bill>
